The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck KGaA
Leadership - Merck KGaA
Phase 2 study of xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): A post hoc activity analysis by blinded independent review committee evaluation.
 
Jean Bourhis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Merck; Merck KGaA; Nanobiotix; Roche
 
S. Peter Eggleton
Employment - Merck Serono
 
Andreas Schroeder
No Relationships to Disclose
 
Heidi Nauwelaerts
Employment - Debiopharm International SA.
 
Florilene Bouisset
Employment - Debiopharm International SA.
 
Xu-Shan Sun
No Relationships to Disclose
 
Yungan Tao
Honoraria - Merck Serono; Seagen
Consulting or Advisory Role - MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology